Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation

This publication has 41 references indexed in Scilit:

• Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.
  Journal of Clinical Investigation, 1998
• Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
  Journal of Clinical Investigation, 1997
• Antiproliferative effects of PCA‐4230, a new antithrombotic drug, in vascular smooth muscle cells
  British Journal of Pharmacology, 1997
• Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
  Cell, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Smooth muscle cell outgrowth from human atherosclerotic plaque: Implications for the assessment of lesion biology
  Journal of the American College of Cardiology, 1992
• Cyclin A is required in S phase in normal epithelial cells
  Biochemical and Biophysical Research Communications, 1992
• Interaction of Platelets with Subendothelium in Rats Treated with PCA-4230, a New Antithrombotic Agent
  Pathophysiology of Haemostasis and Thrombosis, 1992
• The Phenotypes of Smooth Muscle Expressed in Human Atheroma^a
  Annals of the New York Academy of Sciences, 1990
• Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines
  Journal of Medicinal Chemistry, 1988